Regenxbio Inc (RGNX)
15.47
+0.14
(+0.91%)
USD |
NASDAQ |
May 22, 16:00
15.45
-0.02
(-0.13%)
After-Hours: 20:00
Regenxbio Stock Buybacks (Quarterly): -132.01M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -132.01M |
December 31, 2023 | 0.00 |
September 30, 2023 | -6.117M |
June 30, 2023 | 0.00 |
March 31, 2023 | -0.583M |
December 31, 2022 | 0.00 |
September 30, 2022 | -1.12M |
June 30, 2022 | 0.00 |
March 31, 2022 | -0.622M |
December 31, 2021 | 0.00 |
September 30, 2021 | -1.141M |
June 30, 2021 | 0.00 |
March 31, 2021 | -217.06M |
December 31, 2020 | 0.00 |
September 30, 2020 | -1.192M |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.607M |
December 31, 2019 | 0.00 |
Date | Value |
---|---|
September 30, 2019 | -0.949M |
June 30, 2019 | 0.00 |
March 31, 2019 | -0.365M |
December 31, 2018 | 0.003M |
September 30, 2018 | -190.22M |
June 30, 2018 | 0.00 |
March 31, 2018 | -0.342M |
December 31, 2017 | 0.00 |
September 30, 2017 | -0.409M |
June 30, 2017 | -10.70M |
March 31, 2017 | -71.45M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 3.049M |
September 30, 2015 | -148.23M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-217.06M
Minimum
Mar 2021
--
Maximum
Jun 2019
-18.07M
Average
-0.2915M
Median
Stock Buybacks (Quarterly) Benchmarks
Sarepta Therapeutics Inc | -- |
AbbVie Inc | 1.324B |
PTC Therapeutics Inc | -- |
BridgeBio Pharma Inc | -312.32M |
Edgewise Therapeutics Inc | -239.15M |